GDF15 and type 2 diabetes mellitus: The mixed linear models in this study showed that patients with HBP and T2D (most of whom were treated with metformin) exhibited higher circulating GDF15 levels (>1,100 pg/mL and 1,500 pg/mL, respectively) compared to those without these conditions (<700 pg/mL).